For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
Scope of the Report:
This report studies the Cancer Stem Cells market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Stem Cells market by product type and applications/end industries.
Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.
The global Cancer Stem Cells market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Stem Cells.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Thermo Fisher Scientific
- Merck Kgaa
- Stemline Therapeutics
- Miltenyi Biotec
- Oncomed Pharmaceuticals
- Irvine Scientific
- Stemcell Technologies
- Sino Biological
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Cell Culturing
- Cell Separation
- Cell Analysis
- Molecular Analysis
Market Segment by Applications, can be divided into
- Breast Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment